Home
Products
Learn
About
Pricing
Log In
VIR
Asset Logo

Vir Biotechnology Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-16.15%
Annual Growth

5 years average annual capital growth

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.

📈 Performance

Price History*

-61.36%

1M

1Y

All Time

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$5.58

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in VIR

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

25 weeks

💵 Average investment amount

$159

Last time a customer invested in VIR

57 days
VIR investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

50%

Less than 50k

50%
👶 Age of investors

18 - 25

26 - 34

50%

35 - 90

50%
🙋 Legal gender of investors

Female

50%

Male

50%

Pearlers who invest in VIR also invest in...

Bank of New York Mellon Corp., The

BK

🙌 Performance (5Yr p.a)

23.45%

📊 Share price

$73.31 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

104.68%

📊 Share price

$146.29 USD

🙌 Performance (5Yr p.a)

289.18%

📊 Share price

$94.31 USD

📈 HIGH PRICE GROWTH

📊 Share price

$74.02 USD

🙌 Performance (5Yr p.a)

428.93%

📊 Share price

$239.43 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

54.59%

📊 Share price

$9.10 USD

🙌 Performance (5Yr p.a)

0.01%

📊 Share price

$14.10 USD
Compare
Add to watchlist